[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2873574 [NCBI, ExPASy, EBI, Israel, Japan]
Koschinsky M.L.,
Funk W.D.,
van Oost B.A.,
McGillivray R.T.A.;
"Complete cDNA sequence of human preceruloplasmin.";
Proc. Natl. Acad. Sci. U.S.A. 83:5086-5090(1986).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NHLBI resequencing and genotyping service (RS&G);
Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1006.
DOI=10.1006/bbrc.1995.1437; PubMed=7702601 [NCBI, ExPASy, EBI, Israel, Japan]
Daimon M.,
Yamatani K.,
Igarashi M.,
Fukase N.,
Kawanami T.,
Kato T.,
Tominaga M.,
Sasaki H.;
"Fine structure of the human ceruloplasmin gene.";
Biochem. Biophys. Res. Commun. 208:1028-1035(1995).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 1-40; 549-599; 784-829 AND 919-952.
DOI=10.1016/0014-5793(86)80739-6; PubMed=3755405 [NCBI, ExPASy, EBI, Israel, Japan]
Mercer J.F.B.,
Grimes A.;
"Isolation of a human ceruloplasmin cDNA clone that includes the N-terminal leader sequence.";
FEBS Lett. 203:185-190(1986).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
Bingle C.D.;
"Cloning and functional analysis of the human ceruloplasmin gene minimal promoter.";
Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 218-1065.
PubMed=3486416 [NCBI, ExPASy, EBI, Israel, Japan]
Yang F.,
Naylor S.L.,
Lum J.B.,
Cutshaw S.,
McCombs J.L.,
Naberhaus K.H.,
McGill J.R.,
Adrian G.S.,
Moore C.M.,
Barnett D.R.,
Bowman B.H.;
"Characterization, mapping, and expression of the human ceruloplasmin gene.";
Proc. Natl. Acad. Sci. U.S.A. 83:3257-3261(1986).
|
[7]
|
PROTEIN SEQUENCE OF 20-1065.
PubMed=6582496 [NCBI, ExPASy, EBI, Israel, Japan]
Takahashi N.,
Ortel T.L.,
Putnam F.W.;
"Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule.";
Proc. Natl. Acad. Sci. U.S.A. 81:390-394(1984).
|
[8]
|
PROTEIN SEQUENCE OF 158-333; 518-724 AND 858-1065.
PubMed=6571985 [NCBI, ExPASy, EBI, Israel, Japan]
Takahashi N.,
Bauman R.A.,
Ortel T.L.,
Dwulet F.E.,
Wang C.-C.,
Putnam F.W.;
"Internal triplication in the structure of human ceruloplasmin.";
Proc. Natl. Acad. Sci. U.S.A. 80:115-119(1983).
|
[9]
|
PROTEIN SEQUENCE OF 501-905.
PubMed=6940148 [NCBI, ExPASy, EBI, Israel, Japan]
Dwulet F.E.,
Putnam F.W.;
"Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin.";
Proc. Natl. Acad. Sci. U.S.A. 78:790-794(1981).
|
[10]
|
PROTEIN SEQUENCE OF 907-1065.
PubMed=6987229 [NCBI, ExPASy, EBI, Israel, Japan]
Kingston I.B.,
Kingston B.L.,
Putnam F.W.;
"Primary structure of a histidine-rich proteolytic fragment of human ceruloplasmin. I. Amino acid sequence of the cyanogen bromide peptides.";
J. Biol. Chem. 255:2878-2885(1980).
|
[11]
|
PROTEIN SEQUENCE OF 907-1065.
PubMed=6987230 [NCBI, ExPASy, EBI, Israel, Japan]
Kingston I.B.,
Kingston B.L.,
Putnam F.W.;
"Primary structure of a histidine-rich proteolytic fragment of human ceruloplasmin. II. Amino acid sequence of the tryptic peptides.";
J. Biol. Chem. 255:2886-2896(1980).
|
[12]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1007-1061.
PubMed=2355023 [NCBI, ExPASy, EBI, Israel, Japan]
Yang F.M.,
Friedrichs W.E.,
Cupples R.L.,
Banifacio M.J.,
Sanford J.A.,
Horton W.A.,
Bowman B.H.;
"Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing.";
J. Biol. Chem. 265:10780-10785(1990).
|
[13]
|
REVIEW.
DOI=10.1146/annurev.nutr.22.012502.114457; PubMed=12055353 [NCBI, ExPASy, EBI, Israel, Japan]
Hellman N.E.,
Gitlin J.D.;
"Ceruloplasmin metabolism and function.";
Annu. Rev. Nutr. 22:439-458(2002).
|
[14]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138, AND MASS SPECTROMETRY.
TISSUE=Bile;
DOI=10.1074/mcp.M400015-MCP200; PubMed=15084671 [NCBI, ExPASy, EBI, Israel, Japan]
Kristiansen T.Z.,
Bunkenborg J.,
Gronborg M.,
Molina H.,
Thuluvath P.J.,
Argani P.,
Goggins M.G.,
Maitra A.,
Pandey A.;
"A proteomic analysis of human bile.";
Mol. Cell. Proteomics 3:715-728(2004).
|
[15]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-397 AND ASN-762, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1002/pmic.200300556; PubMed=14760718 [NCBI, ExPASy, EBI, Israel, Japan]
Bunkenborg J.,
Pilch B.J.,
Podtelejnikov A.V.,
Wisniewski J.R.;
"Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.";
Proteomics 4:454-465(2004).
|
[16]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-358; ASN-397; ASN-588; ASN-762 AND ASN-926, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[17]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-784 AND TYR-787, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J., ![]()
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[18]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-204, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[19]
|
X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), DISULFIDE BONDS, AND METAL-BINDING SITES.
Zaitseva I.,
Zaitsev V.,
Card G.,
Moshkov K.,
Bax B.,
Ralph A.,
Lindley P.;
"The X-ray structure of human serum ceruloplasmin at 3.1 A: nature of the copper centres.";
J. Biol. Inorg. Chem. 1:15-23(1996).
|
[20]
|
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), METAL-BINDING SITES, AND DISULFIDE BONDS.
DOI=10.1107/S090744490604947X; PubMed=17242517 [NCBI, ExPASy, EBI, Israel, Japan]
Bento I.,
Peixoto C.,
Zaitsev V.N.,
Lindley P.F.;
"Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites.";
Acta Crystallogr. D 63:240-248(2007).
|
[21]
|
VARIANTS THR-63; LEU-477; GLU-544; ILE-551; HIS-793 AND ARG-841.
PubMed=15557511 [NCBI, ExPASy, EBI, Israel, Japan]
Hochstrasser H.,
Bauer P.,
Walter U.,
Behnke S.,
Spiegel J.,
Csoti I.,
Zeiler B.,
Bornemann A.,
Pahnke J.,
Becker G.,
Riess O.,
Berg D.;
"Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.";
Neurology 63:1912-1917(2004).
|
[22]
|
CHARACTERIZATION OF VARIANTS THR-63; GLU-544 AND HIS-793.
DOI=10.1096/fj.04-3486fje; PubMed=16150804 [NCBI, ExPASy, EBI, Israel, Japan]
Hochstrasser H.,
Tomiuk J.,
Walter U.,
Behnke S.,
Spiegel J.,
Krueger R.,
Becker G.,
Riess O.,
Berg D.;
"Functional relevance of ceruloplasmin mutations in Parkinson's disease.";
FASEB J. 19:1851-1853(2005).
|
|
ExPASy Home page
